-- Robert Preidt
WEDNESDAY, Nov. 7 (HealthDay News) -- A mother's age at
menopause may predict her daughter's fertility in terms of eggs
remaining in her ovaries, a new study suggests.
For the study, researchers divided more than 500 Danish women,
aged 20 to 40, into three groups: those whose mothers had an early
menopause (younger than 45); normal menopause (46 to 54 years); or
late menopause (older than 55).
The research team assessed the number of eggs in the women's
ovaries using two accepted methods: levels of anti-Mullerian
hormone and antral follicle count determined by sonography.
Follicles contain the immature egg. They found that both declined
faster in women whose mothers had an early menopause than in those
whose mothers had a late menopause.
After adjusting for other factors such as smoking, contraceptive
use, age and body mass index, the researchers found that average
anti-Mullerian hormone levels declined by almost 9 percent, 7
percent and about 4 percent a year in the women whose mothers had
early, normal or late menopause, respectively.
Antral follicle count declined almost 6 percent, 5 percent and
about 3 percent in the same groups, respectively, according to the
study, published Nov. 7 in the journal
The number of eggs remaining in a woman's ovaries affects her
ability to conceive naturally, and both the number and quality of
eggs decline as women age.
"Our findings support the idea that the ovarian reserve is influenced by hereditary factors. However, long-term follow-up studies are required," study leader Dr. Janne Bentzen, from the Copenhagen University Hospital, said in a journal news release.
The researchers also found that anti-Mullerian hormone levels
and antral follicle count were significantly lower in women who
used birth control pills, compared to non-users. In addition,
antral follicle count in women whose mothers smoked while they were
pregnant was an average of 11 percent lower, but anti-Mullerian
hormone levels were not significantly different.
The effects of birth control pills are likely to be temporary
and unlikely to influence the long-term decline in ovarian
follicles, Bentzen said. But, she added, doctors and women should
be aware of this effect when considering women's reproductive life
spans or any fertility treatment.
The U.S. National Institute of Child Health and Human
Development has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.